Excellent Response to Fam-Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma With CNS Metastasis: A Case Report

Affiliations

• ¹ School of Medicine, Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Brazil.
• ² Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
• ³ Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
• ⁴ Department of Radiology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
• ⁵ Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
• ⁶ Department of Head and Neck Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.